AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026Net selling: insiders sold $824K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$824K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 3 added, 1 cutMore adding
Key stats
Fundamentals Sep 30- Open
- $90.76
- 52-wk high
- $106.03
- High
- $91.84
- 52-wk low
- $78.91
- Low
- $90.09
- Prev close
- $91.04
- Mkt cap
- $17.42B
- P/E
- 22.2x
- Volume
- 1.63M
- Fwd P/E
- 10.1x
- Beta
- 0.47
- Div yield
- 1.05%
- P/S
- 2.0x
- P/B
- 1.4x
- Profit margin
- +9.5%
- Op margin
- +18.0%
- ROE
- +6.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about ZBH filings
Are insiders buying or selling Zimmer Biomet Holdings Inc (ZBH) stock?
Net selling: insiders sold $824K and bought $0 of ZBH stock on the open market in the 90 days to Oct 1, 2026, according to SEC Form 4 filings. The largest was Thornal, Kevin R (Grp Pres-Global Business), who sold $529K. The latest filing was on Sep 15, 2026.
Which members of Congress have traded ZBH recently?
None. No member of Congress disclosed a ZBH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this ZBH smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (2)
- CI
Citadel
$174.7M
added
- P7
Point72
$75.7M
bought
Sells/Trims (1)
- BA
Balyasny
$38.4M
sold
What insiders are doing
How top traders are positioned
No tracked top-trader positions in ZBH right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 3.0% above what analysts expected.
Earnings per share
$2.01 expected
Reports Nov 4, 2026, in 34 days
Estimates as of Sep 30, 2026
EPS expected
$1.86 to $1.91
Revenue expected
24 analysts
Last 30 days
Analysts raising estimates
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.00B | $2.24B | $2.09B | $2.18B |
| Cost of what it sold | $559.3M | $792.4M | $576.2M | $635.5M |
| Gross profit | $1.44B | $1.45B | $1.51B | $1.54B |
| What it spent | ||||
| Research and development | $115.9M | $118.8M | $103.4M | $104.8M |
| Sales and admin | $811.4M | $855.7M | $849.9M | $899.3M |
| Other operating costs | $163.5M | $189.1M | $184.0M | $211.3M |
| Total operating expenses | $1.09B | $1.16B | $1.14B | $1.22B |
| What was left | ||||
| Operating profit | $351.3M | $287.8M | $373.2M | $326.1M |
| Interest on debt | $75.4M | $71.9M | $68.8M | $72.9M |
| Profit before tax | $279.2M | $98.0M | $301.3M | $255.1M |
| Tax | $48.0M | -$39.9M | $63.0M | $55.5M |
| Net profit | $230.9M | $139.5M | $238.1M | $198.3M |
| EBITDA | $638.2M | $453.9M | $538.3M | $328.0M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is mixed
Edwards Lifesciences Corporation (NYSE:EW) Stock Has Average Target Price of $100.27
Leans bullishSep 26Zimmer Biomet (ZBH): Buy, Sell, or Hold Post Q2 Earnings?
NeutralSep 26Zimmer Biomet stock trades at USD 91.57, up 2.10 percent in New York trading
BullishSep 25Zimmer Biomet stock falls 1.31 percent despite higher 2026 guidance
Leans bearishSep 25Zimmer Biomet Holdings, Inc. $ZBH Holdings Lifted by State Street Corp
NeutralSep 24Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now?
NeutralSep 23Minimally Invasive Robotic Surgical System Market Global Report 2026: Benchmark Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker and Zimmer Biomet Now
Leans bullishSep 23Zimmer Biomet stock slips as shares close at USD 94.32
Leans bearishSep 23
Macro
31 macro signals shaping ZBH right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results